Format

Send to

Choose Destination
Blood. 2018 Mar 29;131(13):1486-1489. doi: 10.1182/blood-2017-10-812461. Epub 2018 Feb 12.

Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies.

Author information

1
The Platelet and Neutrophil Immunology Laboratory, BloodCenter of Wisconsin, Milwaukee, WI.
2
Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY.
3
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
4
Division of Hematology/Oncology, New York Presbyterian Hospital, New York, NY; and.
5
Blood Research Institute, BloodCenter of Wisconsin, and.
6
Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
PMID:
29439950
PMCID:
PMC5877442
DOI:
10.1182/blood-2017-10-812461
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center